← Open Payments lookup

RABIATU BANGURA: Open Payments

NPI 1740903004 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,797 in 80 payments from 16 companies in 2025. Trend: 2023 $199 · 2024 $2,469 · 2025 $1,797

Food & beverage: $1,797
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.12$303
Lundbeck LLC13$230
Axsome Therapeutics, Inc.6$191
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$188
Neurocrine BioSciences, Inc.6$152
Otsuka America Pharmaceutical, Inc.6$141
Janssen Pharmaceuticals, Inc4$106
Vanda Pharmaceuticals Inc.3$85
Alkermes, Inc.3$76
Luye Pharma (USA) Ltd.2$71

Products named: COBENFY, Auvelity, CAPLYTA, REXULTI, INGREZZA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, HETLIOZ.

Industry payments across MD — which companies pay providers there.